Programme TEST PAGE - Intelligent Health
Tickets

Programme TEST PAGE

 

 

    Active Filters
  • Wednesday 07th
  • 07:30 - 09:00
    REGISTRATION
  • 09:20 - 09:25
    WELCOME Inspired Minds Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS Plenary
    • Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS

  • 09:25 - 09:30
    WELCOME Novartis Foundation Dr Ann Aerts, Head of Novartis Foundation Plenary
    • Dr Ann Aerts, Head of Novartis Foundation

  • 09:30 - 09:40
    WELCOME and chairperson’s opening remarks Babita Sharma, Broadcaster and Author Plenary
    • Babita Sharma, Broadcaster and Author

  • 09:40 - 10:05
    HEADLINER: The new era of precision health: from precision discovery to delivery Elena Bonfiglioli, GM, Global Healthcare Strategy Lead, Pharma and Life Sciences, Microsoft Plenary

    Healthcare professionals use multiple data sources, each and every day. Clinicians rely on several types, combinations, and sources of data, such as imaging, time series data, and structured and unstructured clinical data. This data allows healthcare professionals to become more multidisciplinary and contribute with different perspectives as they arrive to a diagnosis and decide on patient management.

     

    Methods to merge multiple sources and modalities to implement in patient care and R&D is happening now. By pairing Microsoft’s computational services, cloud, and artificial intelligence (AI) with drug discovery and development capabilities, we can work together to discover new medicines in a more efficient and innovative way. Through these diverse multimodal data sets and computational AI, we can increase the impact of treatment and provide better data-driven insights to deliver the right medicine to the right patient at the right time.

     

    • Elena Bonfiglioli, GM, Global Healthcare Strategy Lead, Pharma and Life Sciences, Microsoft

  • 10:05 - 10:30
    HEADLINER Leveraging AI for Personalised Intelligent Engagement Marco Giannitrapani, VP Global Data & Analytics (Commercial), Roche Plenary

    Examining the opportunities and challenges in leveraging AI for personalised engagement to  health care providers (HCP). Reflections on how AI can support the delivery of the right content, at the right time, with the right channel to each HCP. 

    • Marco Giannitrapani, VP Global Data & Analytics (Commercial), Roche

  • 10:30 - 10:55
    HEADLINER Why are we here? Nicholas Kelley, Director Data Science & A.I. Innovation, Novartis

    Does Basel have the right ingredients to feature as a true Global AI Health Hub?

    What do the latest AI developments actually mean for health?

    And most importantly, does new AI tech really translate into transformative power for the health sector?

    Nick will help us start a discussion aimed at answering the questions above, as well as provide some inspiring examples from around the Novartis ecosystem.

    • Nicholas Kelley, Director Data Science & A.I. Innovation, Novartis

  • 10:55 - 11:30
    REFRESHMENTS & NETWORKING
  • ROOM: EVENT HALL
    • 11:30 - 11:55
      HEADLINER: Building towards an equitable and sustainable Future of Health Lucien Engelen, Edge Fellow, Deloitte Center for the Edge, Deloitte
      Patricia Gee, Partner in Life Sciences and Leader Future of Health Initiatives, Deloitte Switzerland       Plenary

      Health equity is the fair and just opportunity for every individual to achieve their full potential in all aspects of health and well-being. As we move into a Future of Health driven by highly disruptive technologies, radically interoperable data and increased health consumerism, we must tackle how to harness and accelerate these innovations to address disparities existing across populations and countries.It will take the entire ecosystem to come together in a joint mission to make a sustained and significant impact in health equity across all drivers of health: social, economic, and environmental. Join us to hear more insights and potential ideas for tackling these tough challenges and take part in creating an impact that matters for the Future of Health.

      • Lucien Engelen, Edge Fellow, Deloitte Center for the Edge, Deloitte

      • Patricia Gee, Partner in Life Sciences and Leader Future of Health Initiatives, Deloitte Switzerland

    • 11:55 - 12:35
      PANEL DISCUSSION: CyberSecurity: essential strategies for incident response and recovery Dr Sabina Magalini, PANACEA coordinator; Senior Surgeon of Emergency Trauma, Gemelli University Hospital
      Richard Plumb, Cyber Threat Intelligence Lead, NHS Digital
      Reuven Aronashvili, Founder & Chief Executive Officer, CYE
      Omar Khawaja, Chief Information Security Officer, Highmark Health
      Moderator: Dylan Johnston, Chief Executive Officer, MOD1 AG       Plenary

      including plans to mitigate risk, prioritize actions, and develop vital approaches to managing digital health IT and mounting a defence.

      • Dr Sabina Magalini, PANACEA coordinator; Senior Surgeon of Emergency Trauma, Gemelli University Hospital

      • Richard Plumb, Cyber Threat Intelligence Lead, NHS Digital

      • Reuven Aronashvili, Founder & Chief Executive Officer, CYE

      • Omar Khawaja, Chief Information Security Officer, Highmark Health

      • Moderator: Dylan Johnston, Chief Executive Officer, MOD1 AG

    • 12:35 - 13:00
      AI IN GLOBAL HEALTH: HEADLINER Equalizing health, personalizing experiences, and removing bias in AI Dr Ewelina Türk, SVP Medical Products, Ada Health Plenary

      Technology has a pivotal role to play in addressing the ongoing and growing challenges facing healthcare such as access, quality and outcomes. AI is now certainly able to make a positive impact on a global scale. However, it must be built and trained in a way so that it can interpret the right knowledge in the right way and apply localised or personal variables to avoid bias and improve equality – such as geography, risk factors, disease prevalence and population need. In healthcare, quality is key, and human oversight is imperative to ensure accuracy, trust and positive iteration.

      In this session, Ewelina shares the challenges facing healthcare, ways that AI is helping address these issues, and steps that Ada has taken to avoid bias and provide accurate health advice to all.

      • Dr Ewelina Türk, SVP Medical Products, Ada Health

  • ROOM: MCH LOUNGE
    • 12:30 - 13:15
      WORKSHOP 1: PANEL DISCUSSION: Using data to improve decision-making in population health Mathieu Morand – Senior Manager, Digital & Health Financing, City Cancer Challenge
      Valerie Lasry, Director, Europe, Middle East, Africa and Latin America, NuraLogix Corporation
      Ardy Arianpour, CEO & Co-Founder, Seqster
      Rigveda Kadam, Deputy Director, Digital Health, FIND, the global alliance for diagnostics
      Moderator: Bruno Villetelle, Head of Data and Digital, Novartis Global Drug Development       Track 1
      • Mathieu Morand – Senior Manager, Digital & Health Financing, City Cancer Challenge

      • Valerie Lasry, Director, Europe, Middle East, Africa and Latin America, NuraLogix Corporation

      • Ardy Arianpour, CEO & Co-Founder, Seqster

      • Rigveda Kadam, Deputy Director, Digital Health, FIND, the global alliance for diagnostics

      • Moderator: Bruno Villetelle, Head of Data and Digital, Novartis Global Drug Development

  • 13:00 - 14:00
    LUNCH & NETWORKING
  • PLENARY
    • 14:00 - 14:20
      HEADLINER The power of platforms to transform health care Dr John Halamka, President, Mayo Clinic Platform Plenary

      True transformation of the health care sector requires us to move from pipeline thinking to a platform approach. To do this, we must capture diverse data sources at scale, constantly derive new insights from that data and create closed-loop solutions in a highly repeatable model. This presentation will focus on the work of Mayo Clinic Platform to create this model through privacy-protecting, federated, de-identified data behind glass that protects both data and intellectual property and the partnerships required to enable the greatest impact.

      • Dr John Halamka, President, Mayo Clinic Platform

    • 14:20 - 14:40
      DEEP DIVE TECH TALK Accelerating Intelligent Health: The Role of Privacy-Enhancing Technology Dr. Suraj Kapa, SVP Healthcare, TripleBlind Plenary

      There are evolving needs to increase the types, sources, and global distribution of data in supporting the success and scaling of digital health opportunities. However, current processes to support data collaboration are limited due to the need to de-identify data prior to making it available for analysis, regulatory hurdles related to moving data outside of institutional or geographic data silos, and increasing institutional focus on a desire to have more fine grained control over how data is accessed and by whom. This has led to the growth of a variety of privacy enhancing technologies. This talk will focus on the current barriers that exist in achieving scalably efficient global data collaboration and current and future approaches to solve these issues.

      • Dr. Suraj Kapa, SVP Healthcare, TripleBlind

    • 14:40 - 15:00
      HEADLINER The role of big tech giants in reimagining the future of Healthcare Dr Sahar Hashmi, CEO, Myriad Consulting LLC; Faculty Instructor, Harvard University Plenary

      With the recent acquisition of telehealth platform (One Medical) by the big tech giant, Amazon, it is intriguing to learn if Amazon has the potential to establish a whole healthcare ecosystem and revolutionize healthcare in the future. While big tech giants like Amazon, Apple, Walmart and Google, among other big and small players, race to capture the healthcare consumer market, how could this race impact the customers/patients and providers?

      • Dr Sahar Hashmi, CEO, Myriad Consulting LLC; Faculty Instructor, Harvard University

    • 15:00 - 15:40
      PANEL DISCUSSION: Addressing interoperability and barriers to adoption to create a future driven by precision health Dr. Jim Ritchie, Consultant Renal Physician; Chief Clinical Information Officer; Deputy Director for Research and Innovation, Northern Care Alliance NHS Foundation Trust
      Dr. Felice Burn, Clinical Artificial Intelligence Lead, Kantonsspital Aarau AG
      Theresa Reiker, Associate Director of Population Health, Novartis Foundation
      Moderator: Antonio Russo, Innovation Leader and Partner, Head of Analytics & Cognitive, Deloitte Switzerland       Plenary
      • Removing silos to offer more integrated care
      • Best Practice in Integrated Care – What does success look like?
      • Challenges and opportunities
      • Focus on patient-centric care
      • Addressing inherent privacy issues
      • Dr. Jim Ritchie, Consultant Renal Physician; Chief Clinical Information Officer; Deputy Director for Research and Innovation, Northern Care Alliance NHS Foundation Trust

      • Dr. Felice Burn, Clinical Artificial Intelligence Lead, Kantonsspital Aarau AG

      • Theresa Reiker, Associate Director of Population Health, Novartis Foundation

      • Moderator: Antonio Russo, Innovation Leader and Partner, Head of Analytics & Cognitive, Deloitte Switzerland

    • 15:40 - 16:00
      HEADLINER Harnessing the power of platform technology for medical imaging AI Dr Imran Siddiqui, UK/I Radiology Medical Advisor, Bayer Plc Plenary

      Healthcare services around the world face growing resource and regulatory challenges of deploying multiple AI technologies. Platform technology is well known in many industries and has the potential to revolutionise deployment within healthcare. Understanding the established workflow is a critical step towards effective integration, allowing organisations, healthcare professionals and subsequently their patients to leverage the benefits of AI collectively through one single platform.

      • Dr Imran Siddiqui, UK/I Radiology Medical Advisor, Bayer Plc

  • ROOM: MCH LOUNGE
    • 14:00 - 16:00
      African Startup Pitches INTRODUCTION:
      Lucy Setian, Director of Digital Transformation, Novartis Foundation
      HOST:
      Sharon Batamuriza, Senior Program Manager, Bridge for Billions
      Helge Buess, Associate Director Population Health, Novartis Foundation
      STARTUPS:
      PITCH 1
      Hannan Hashmi, Co-CEO, Kapsule
      &
      Femi Amoo, CTO & Head of Engineering, Kapsule
      PITCH 2
      Ginyu Innocentia KwalarToh, CEO & Founder, Klarah
      PITCH 3
      Babajide Oke, CEO & Founder, Render Health
      &
      John Shoboiki, CMO, Render Health
      PITCH 4
      Peace Iraguha, COO & Co-founder, Lifesten
      PITCH 5
      Theophila Huriro Uwacu, Director, E-Heza Data Solutions
      PITCH 6
      Aloys Rukundo, Founder & CEO, Hellomed
      PITCH 7
      Nelson Igbiriki, CEO & Co-Founder, Medtech Africa       Track 1
      • INTRODUCTION:

      • Lucy Setian, Director of Digital Transformation, Novartis Foundation

      • HOST:

      • Sharon Batamuriza, Senior Program Manager, Bridge for Billions

      • Helge Buess, Associate Director Population Health, Novartis Foundation

      • STARTUPS:

      • PITCH 1

      • Hannan Hashmi, Co-CEO, Kapsule

      • &

      • Femi Amoo, CTO & Head of Engineering, Kapsule

      • PITCH 2

      • Ginyu Innocentia KwalarToh, CEO & Founder, Klarah

      • PITCH 3

      • Babajide Oke, CEO & Founder, Render Health

      • &

      • John Shoboiki, CMO, Render Health

      • PITCH 4

      • Peace Iraguha, COO & Co-founder, Lifesten

      • PITCH 5

      • Theophila Huriro Uwacu, Director, E-Heza Data Solutions

      • PITCH 6

      • Aloys Rukundo, Founder & CEO, Hellomed

      • PITCH 7

      • Nelson Igbiriki, CEO & Co-Founder, Medtech Africa

  • 16:00 - 16:20
    REFRESHMENTS & NETWORKING
  • PLENARY
    • 16:20 - 16:40
      HEADLINER Healthcare’s Yin and Yang: Analytics and Clinical Empathy Dr Daniel Knecht, VP, Chief Clinical Innovation Officer, CVS Caremark Plenary

      Engaging patients with their care supports better health and lower costs. The premise is simple: engagement can help patients adhere to therapy and prevent gaps in care that contribute to subpar outcomes and unnecessary spending. However, the U.S. healthcare system has an engagement problem. Even prior to the pandemic, fewer than 50% of patients were highly engaged in their care. This is particularly problematic for people managing complex and chronic conditions. 

      Insights and predictions derived from claims data combined with digital tools and patient reported outcome metrics can help us take a more holistic look at a person’s health and even address co-morbidities. However, that alone is not enough. Clinical empathy – the sense of human connection and emotion between provider and patient – remains critical as we seek to improve health care.

      Advanced analytics – making data work smarter – and clinically empathetic human interactions are intimately related and together help drive increasingly personalized and timely patient engagement that will elevate the standard of care in the U.S.

      • Dr Daniel Knecht, VP, Chief Clinical Innovation Officer, CVS Caremark

    • 16:40 - 17:20
      PANEL DISCUSSION: Does a tech-driven healthcare sector, fuelled by personalised biometric data, have the potential to ease pressure on centralised healthcare systems and the expenses that go with that ? Caoimhe Vallely-Gilroy, Former Global Head of Digital Health & Therapeutics, Healthcare Business of Merck
      Victor Savevski, Chief innovation Officer and AI Center Director, Humanitas Research Hospital
      Lucy Setian, Director of Digital Transformation, Novartis Foundation
      Moderator: Lucas Scherdel, Director at DayOne - Healthcare Innovation       Plenary
      • Examining the benefits of digital therapeutics in improving health outcomes in patients.
      • Are partnerships between digital therapeutics companies and big Pharma critical for this success? 
        • Merging the use of big data, advanced analytics, and hardware engineering with Big Pharma biological expertise and institutional know-how 
      • How should regulators and governments adjust to support this blossoming ecosystem?
      • Will digital health solutions exacerbate existing disparities?
      • Caoimhe Vallely-Gilroy, Former Global Head of Digital Health & Therapeutics, Healthcare Business of Merck

      • Victor Savevski, Chief innovation Officer and AI Center Director, Humanitas Research Hospital

      • Lucy Setian, Director of Digital Transformation, Novartis Foundation

      • Moderator: Lucas Scherdel, Director at DayOne - Healthcare Innovation

    • 17:20 - 17:30
      Welcome from Canton Basel-Stadt to Networking Drinks Dr. Lukas Engelberger, Member of the Government of the Canton Basel-Stadt and Head of the Public Health Department Plenary
      • Dr. Lukas Engelberger, Member of the Government of the Canton Basel-Stadt and Head of the Public Health Department

  • ROOM: MCH LOUNGE
    • 16:20 - 17:40
      African Startup Pitches Hosts:
      Sharon Batamuriza, Senior Program Manager, Bridge for Billions
      Helge Buess, Associate Director Population Health, Novartis Foundation
      STARTUPS:
      PITCH 1
      Chris Mulhall, CEO & Founder, Remote Doctors for All
      &
      Peter Hurst BDM, Remote Doctors for All
      PITCH 2
      Moses Mukundi, CEO, Eden Care
      PITCH 3
      Clivate Maiba, CEO, Denga Logistics Ltd
      PITCH 4
      Affiong Osuchukwu, Co-Founder, Digi-Dibia Health-Tech Ltd
      PITCH 5
      Audace Nakeshimana, Founder, Insightiv       Track 1
      • Hosts:

      • Sharon Batamuriza, Senior Program Manager, Bridge for Billions

      • Helge Buess, Associate Director Population Health, Novartis Foundation

      • STARTUPS:

      • PITCH 1

      • Chris Mulhall, CEO & Founder, Remote Doctors for All

      • &

      • Peter Hurst BDM, Remote Doctors for All

      • PITCH 2

      • Moses Mukundi, CEO, Eden Care

      • PITCH 3

      • Clivate Maiba, CEO, Denga Logistics Ltd

      • PITCH 4

      • Affiong Osuchukwu, Co-Founder, Digi-Dibia Health-Tech Ltd

      • PITCH 5

      • Audace Nakeshimana, Founder, Insightiv

  • 17:30 - 17:35
    CLOSE OF SUMMIT DAY ONE
  • 17:35 - 17:35
    NETWORKING DRINKS
  • Thursday 08th
  • 08:00 - 09:00
    REGISTRATION
  • 09:00 - 09:05
    WELCOME Inspired Minds Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS Plenary
    • Sarah Porter, CEO and Founder, InspiredMinds! UN Advisor, LAWS

  • 09:05 - 09:20
    WELCOME Chairperson Babita Sharma, Broadcaster and Author Plenary
    • Babita Sharma, Broadcaster and Author

  • 09:20 - 09:45
    HEADLINER Computational Collective Surgical Consciousness Dr Ozanan Meireles, Surgeon at Massachusetts General Hospital; Assistant Professor of Surgery at Harvard Medical School; Co-Founder and Director of the Surgical Artificial Intelligence and Innovation Laboratory (SAIIL) at the Massachusetts General Hospital. Plenary

    Artificial Intelligence will be an integral part of surgery in the near future. The use of computer vision and advanced machine learning techniques can change how operations will be performed by allowing surgeons to contribute to and benefit from the knowledge of their colleagues worldwide, conceptually creating a computational collective surgical consciousness. This would enhance surgeon’s skill acquisition and cognitive performance with the potential of mitigating intraoperative adverse events, improving patient care, and reducing health care costs.

    • Dr Ozanan Meireles, Surgeon at Massachusetts General Hospital; Assistant Professor of Surgery at Harvard Medical School; Co-Founder and Director of the Surgical Artificial Intelligence and Innovation Laboratory (SAIIL) at the Massachusetts General Hospital.

  • 09:45 - 10:25
    PANEL DISCUSSION The Rise of Femtech: How can digital technology and AI help deliver the women’s health strategy? Mame Daba Diouf, Business Unit & Project Manager, IT4Life
    Valentina Sartori, Partner, Leader of QuantumBlack in Switzerland, QuantumBlack, AI by McKinsey
    Sofiat Akinola, Director, Health Policy and External Affairs, Roche
    Moderator: Jiskia Reis, Corporate Innovation Lead, Health, Plug and Play GmbH     Plenary
    • Addressing the gender health gap
    • Driving ‘femtech’ innovation and unlocking opportunities in women’s healthcare
    • Empowering women to take control of their wellness
    • Mame Daba Diouf, Business Unit & Project Manager, IT4Life

    • Valentina Sartori, Partner, Leader of QuantumBlack in Switzerland, QuantumBlack, AI by McKinsey

    • Sofiat Akinola, Director, Health Policy and External Affairs, Roche

    • Moderator: Jiskia Reis, Corporate Innovation Lead, Health, Plug and Play GmbH

  • 10:25 - 10:45
    REFRESHMENTS & NETWORKING
  • TRACK 1: PRACTICAL, REAL-WORLD AI USE CASES IN HEALTHCARE. Examining the potential to transform care delivery and life science research, challenges faced and lessons learnt. ROOM: EVENT HALL Chair: Babita Sharma, Broadcaster and Author
    • 10:45 - 11:05
      AI IN ACTION HEADLINER Augmenting Imaging Data with AI to bring Precision Therapies to Healthcare & Life Sciences Jacques Gilbert, Senior Director Strategy – Healthcare, Nuance Communications

      Artificial Intelligence in imaging is detecting diseases like cancer and aneurysms in early stage to target treatment options and deliver better outcomes. Now, an AI-powered cloud platform is extending patient specific data and diagnostic insights beyond the radiologists and into the connected healthcare ecosystem of providers, health insurers, life sciences and medical technology companies. This keynote will spotlight how AI generated imaging data is shared, scaled and used in care workflows to identify patients for clinical trials and deliver insights into precision therapeutics that cross the care continuum.

      • Jacques Gilbert, Senior Director Strategy – Healthcare, Nuance Communications

    • 11:05 - 11:25
      Use Case 2 Robust AI For Healthcare: Taming Complex Datasets With Graph Neural Networks Luke Markham, ML Engineer, Graphcore

      Improving patient outcomes and drug development with AI relies on high-quality models that clinicians can trust. Shoehorning real-world data into formats consumed by traditional AI models can create AI that lacks ‘common-sense’, and limits performance.

      Graph abstractions are a flexible format well-suited to real-world data, and the accompanying branch of deep learning: Graph Neural Networks (GNNs), enable powerful models to be built on top of them. Join Luke for practical and effective use-cases of GNNs, and how to run them efficiently in production.

      • Luke Markham, ML Engineer, Graphcore

    • 11:25 - 12:05
      PANEL DISCUSSION Harnessing Virtual Health & Care solutions to transform population health and equity Dr Carl Leitner, Technical Officer - Digital Health & Innovation, World Health Organisation
      Prof. S. Yunkap Kwankam, PhD., Executive Director, International Society for Telemedicine and eHealth (ISfTeH)
      Caroline Perrin, PhD, Executive Director, Geneva Digital Health Hub (gdhub)
      Marco Obiso, Chief AI of the Digital Networks & Society Department, Telecommunication Development Bureau, International Telecommunication Union (ITU)
      Jürg Hutter, Senior Product Manager Digital Health, Swiss Post Communication Services Ltd
      Moderator: Dr. Ann Aerts, Head, Novartis Foundation
      • Dr Carl Leitner, Technical Officer - Digital Health & Innovation, World Health Organisation

      • Prof. S. Yunkap Kwankam, PhD., Executive Director, International Society for Telemedicine and eHealth (ISfTeH)

      • Caroline Perrin, PhD, Executive Director, Geneva Digital Health Hub (gdhub)

      • Marco Obiso, Chief AI of the Digital Networks & Society Department, Telecommunication Development Bureau, International Telecommunication Union (ITU)

      • Jürg Hutter, Senior Product Manager Digital Health, Swiss Post Communication Services Ltd

      • Moderator: Dr. Ann Aerts, Head, Novartis Foundation

    • 12:05 - 12:25
      Keynote Use Case 3 Can AI solve the global radiology crisis? Dr Aengus Tran, Co-Founder and Clinical AI Director, annalise.ai

      annalise.ai

      • Dr Aengus Tran, Co-Founder and Clinical AI Director, annalise.ai

    • 12:25 - 12:45
      AI IN GLOBAL HEALTH: Use Case 4 Supporting innovations in diagnostics for LMICs Rigveda Kadam, Deputy Director, Digital Health, FIND, the global alliance for diagnostics

      In healthcare, emerging technologies like AI have been used to augment interpretation of radiology, increase diagnostic accuracy in evaluation of cough and auscultation of lung sounds, and aid in clinician decision-making.  However, several challenges in use of AI-based diagnostics in low and middle income countries are present, such as availability and use of representative training data and agile evaluation processes for generating evidence on the safety and quality of AI-based diagnostics. Rigveda will present on FIND’s work to provide support to product developers, on evidence generation and on policy shaping around AI-based diagnostics in LMICs.

      • Rigveda Kadam, Deputy Director, Digital Health, FIND, the global alliance for diagnostics

  • TRACK 2: DEEP DIVE AI TECH TALKS IN HEALTHCARE Fundamental breakthroughs using AI which will change lives and reshape healthcare ROOM: BOSTON Chair: Anca del Río, Lead Health Tech Community & Stakeholder Relations, DayOne - Healthcare Innovation
    • 10:45 - 11:05
      Tech Talk 1: Automated Classification and Entity Extraction from Clinical Trial Master Files Veysel Kocaman, Head of Data Science (Healthcare), John Snow Labs

      This talk will cover lessons learned from an end-to-end migration process of the clinical trial master files in Novartis. We present a solution based on the natural language processing (NLP) system that delivers a future-proof architecture that comprises OCR based text extraction, language detection, layout & content-based document classifiers, more than 40+ different DL based named entity recognition models, handwritten text extraction, and artifact-based post-processing rules to automate the migration between different document management systems in an air-gapped network. The delivered solution provides 80% reduction of manual labor and migration timeline and is proven in major real-world projects with state of the art accuracy.

      • Veysel Kocaman, Head of Data Science (Healthcare), John Snow Labs

    • 11:05 - 11:25
      Tech Talk 2 Applications of Natural Language Processing in Healthcare: Opportunities and challenges Elif Ozkirimli, Head of Products, Computational Science and Analytics, Integrated Informatics, Roche AG

      Advances in Natural Language Processing (NLP) have accelerated the adoption of these approaches in all domains where text data harbors very rich information content. The field has even achieved success in applications to domain specific languages such as those used in scientific publications, medical records or even human codified representation of biochemicals. However, one challenging aspect of processing data in these domains is that data do not evenly sample all of the available knowledge space, making it hard to find the interesting or useful “needles in the haystack”. I will briefly present some novel approaches that address this data scarcity problem for three different tasks: customer engagement, scientific literature classification, and protein-compound affinity prediction.

      • Elif Ozkirimli, Head of Products, Computational Science and Analytics, Integrated Informatics, Roche AG

    • 11:25 - 11:45
      Tech Talk 3: A comprehensive AI in healthcare evaluation framework and its application Dr Sandeep Reddy, Director, Healthcare Management Program, Deakin University

      While there has been incredible excitement about the prospects of AI in healthcare and increasing funding to support its application, there has been a minimal translation of the potential, as evidenced by the few applications used in clinical practice currently. This is mainly because many AI applications are not developed for real-world integration and use by clinical practitioners. We developed a comprehensive AI in healthcare evaluation framework to address this translational gap. This presentation outlines the evaluation framework, its components, and findings from its application. We anticipate that the evaluation framework will be helpful for AI application development in healthcare.

      • Dr Sandeep Reddy, Director, Healthcare Management Program, Deakin University

    • 11:45 - 12:05
      Tech Talk 4 Anomalies in Large Organs and How The Selection of the Correct Hardware Acceleration Technology and the Right Building Blocks to Support This Workload is Essential Amos Ankrah, Boston Solution Specialist, Boston
      Andrew Addison, Senior Technologist, Boston

      Liver cancers account for 750,000 new cases globally on a yearly basis and in a post-Covid world medical institutions are struggling with the management of cancer cases. This session outlines how Boston Medical is developing an AI algorithm to detect anomalies in large organs. The talk provides a deep dive into the platform that Boston uses for its AI development and dives deeper into the choice of Acceleration Technologies in the marketplace. The aim is to provide guidance for the many options out there.

      • Amos Ankrah, Boston Solution Specialist, Boston

      • Andrew Addison, Senior Technologist, Boston

    • 12:05 - 12:25
      Tech Talk 5: Combining the AI and neural implants to restore the sensorimotor function in patients Prof Dr Stanisa Raspopovic, Dep. of Health Sciences and Technology, ETH Zürich

      Advances in nervous system interfacing present a promising venue for rehabilitation of individuals with different neurological disabilities. Despite a wide range of possibilities for human-machine interfacing, the nature of the optimal human-machine interaction remains poorly understood. 

      We have pioneered a human-machine system that translates prosthetic sensors’ read-outs into “language” understandable by the nervous system, using computational models.  A “sensing leg,” for lower- limb amputees, by connecting sensors from the prosthetic knee and under the foot to the residual PNS, transduces the readout of the sensors into stimulation parameters.

      The “smart orthosis” for diabetics “speaks” to their residual healthy nerves with a similar philosophy. These experiments not only provided clear evidence of the benefit of neuromodulation for diabetics or lower-limb amputees but also provided insights into fundamental mechanisms of supraspinal integration of the restored sensory modalities

      • Prof Dr Stanisa Raspopovic, Dep. of Health Sciences and Technology, ETH Zürich

    • 12:25 - 12:45
      Tech Talk 6 Personalization of health experiences with privacy-preserving AI Dr. Anita Prinzie, Product Manager, Omina Technologies

      Personalized healthcare aims to deliver the best care to each person throughout their life. It personalizes the entire patient experience journey with personalized prevention and health monitoring, personalized diagnosis, personalized treatments, personalized recovery and rehabilitation.
      Traditional recommender systems as used in retail (e.g. Netflix) cannot be used for personalizing high-stake patient experiences based on sensitive personal data. Instead, a privacy preserving and trustworthy AI pipeline should be adopted supporting granular and evolving data consents and adaptive to changing data privacy legislations, a privacy-preserving recommender system along with a privacy-aware AI solution evaluation, reporting and communication.

      • Dr. Anita Prinzie, Product Manager, Omina Technologies

  • TRACK 3: INNOVATION STAGE: AI HEALTH TRANSFORMERS. Hear from the leaders of the most disruptive AI health tech companies of tomorrow. ROOM: SHANGHAI Chair: Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland
    • 10:45 - 11:05
      Innovation Insight 1: How data can power more informed clinical recommendations and higher adherence, driving better healthcare outcomes amongst chronic disease patients Mukesh Bansal, Chief Operating Officer & Co-Founder, Phable
      Anuraag Dubey, Chief Product Officer, Phable

      As India’s largest Chronic Disease Management Platform, Phable receives static and longitudinal health data along with adherence behaviour from patients and doctors managing chronic conditions. This offers new insights into the interaction between patient condition, drugs, diet and fitness regimen, enabling better patient outcomes that are confirmed by evidence derived from prospective and retrospective studies (RWE)

      • Mukesh Bansal, Chief Operating Officer & Co-Founder, Phable

      • Anuraag Dubey, Chief Product Officer, Phable

    • 11:05 - 11:25
      Innovation Insight 2 The Rise of Simple Models - Explainable AI (xAI) in Medicine Samuel Demharter, PhD, Head of Bioinformatics, Target & Biomarker Discovery, Abzu

      Modern digital and assay technology paired with powerful computational methods has changed the way we discover biomarker signatures. At Abzu we have developed an effective workflow based on explainable AI, that extracts the best possible predictive models from high-dimensional data, even when the sample size is relatively small. In this talk we will show how we are using a new interpretable approach to machine-learning to help customers generate highly predictive tools from challenging omics and multi-omics datasets and get the most out of valuable clinical and experimental data.

      • Samuel Demharter, PhD, Head of Bioinformatics, Target & Biomarker Discovery, Abzu

    • 11:25 - 11:45
      Innovation Insight 3 From intractable to interactable: unlocking the value of sensitive healthcare datasets with distributed data science Blaise Thomson, CEO & Founder, Bitfount

      The sensitive nature of healthcare data makes collaboration of any kind extremely difficult. Distributed data science is a new privacy-preserving technique for overcoming this issue by leaving data ‘in place’ and sending algorithms to the data. In this talk, we’ll introduce the fundamentals of distributed data science, including federated machine learning with additional privacy measures, and describe a use-case involving classification of cancer metastases in whole-slide images of histological lymph node sections, where the data is drawn from multiple hospitals with different apparatus used to produce the images.

      • Blaise Thomson, CEO & Founder, Bitfount

    • 11:45 - 12:05
      Innovation Insight 4 "click to save: optimising healthy aging with technology" Rene Gilvert, Founder and CEO, OptiChroniX

      With a diminishing workforce and increasing numbers of people with dementia, the answer cannot be more of the same. A growing literature supports early behavioural intervention. This can be delivered on a phone, so let’s try something new to battle the silent pandemic.

      • Rene Gilvert, Founder and CEO, OptiChroniX

    • 12:05 - 12:25
      Innovation Insight 5 Structuring Today’s Data to Save Tomorrow’s Lives Severin Kappeler, Product Manager, Acodis

      80% of the world’s data that could be used to make critical decisions is unstructured data, aka dark data. In health, this information is typically locked in documents like patient data, studies, leaflets, and health regulations. The issue is that these documents are hard to analyse and process in large amounts because they are neither machine-readable nor ready for downstream consumption.

      Breakthroughs in AI are now available to extract and structure the correct information at scale to provide NLP and data teams with the crucial context (including headers, tables, pictures, and handwriting) for accurate data analytics. Join this talk to learn how to leverage your unstructured data, discover new insights, and save lives with AI.

      • Severin Kappeler, Product Manager, Acodis

    • 12:25 - 12:45
      Innovation Insight 6 Using AI and smart sensors to diagnose and manage neurodegenerative diseases Dr. George Chatzipirpiridis, COO & Co-founder, Magnes AG

      Magnes has developed a wearable solution to analyse human walking movements by using AI algorithms. It enables real-world data collection from patients. Magnes solution can detect gait events in real-time and provide biofeedback to the patient. This allows personalization of therapies and data-based decision-making for healthcare professionals. Potential use cases range from management of neurological disorders, real-time risk of fall assessment / fall prevention, and digital biomarkers for new pharmaceuticals.

      • Dr. George Chatzipirpiridis, COO & Co-founder, Magnes AG

  • TRACK 4: AI UNDER THE HOOD: WORKSHOPS. ROOM: DELHI
    • 10:45 - 11:45
      Workshop 2: Unleashing the Power of Data through Scaled Deployment of Data Products Nishant Sinha, Director, AI & Automation, Deloitte Switzerland
      Peter Hackel, Head of Data Products, Takeda Pharma
      Susan Tillmann, Head Digital & Data Science, Global Manufacturing and Supply, Takeda Pharma

      Takeda’s global manufacturing, supply, and quality organizations (GMS GQ) are utilizing the power of data and AI to transform a landscape of siloed data sets, into consolidated contextualized organizational data – A single source of access to contextualized data enables building and scaling of data products, empowering the organization to make proactive data driven decisions, increase innovations and actualize time savings. Ultimately translating to enhanced quality and delivery of treatment to patients.

      • Nishant Sinha, Director, AI & Automation, Deloitte Switzerland

      • Peter Hackel, Head of Data Products, Takeda Pharma

      • Susan Tillmann, Head Digital & Data Science, Global Manufacturing and Supply, Takeda Pharma

    • 11:50 - 12:50
      Workshop 3: Data-Driven Decision-Making in Healthcare Panellists:
      Arnaud Wilmet, MD, Chief Medical Information Officer, Nuance
      Julie Agez, IT Project Manager Antoine Lacassagne Centre for the Fight against Cancer, Unicancer Network
      Moderator; Elena Bonfiglioli, GM, Worldwide Healthcare, Strategy Lead, Pharma and Life Sciences, Microsoft

      Join us for an interactive conversation centered on unlocking the value of healthcare data. If doctors and researchers are empowered to effectively manage and analyze data, they can prepare for future pandemics, discover new therapeutics faster, and observe symptoms earlier. We will discuss how to implement purpose-built cloud solutions to harness the value of healthcare data and how applying AI can help accelerate breakthroughs. You will get an opportunity to hear from health and life sciences leaders on use cases of implementing cloud and AI to support clinical decision making when patients need it most.

      • Panellists:

      • Arnaud Wilmet, MD, Chief Medical Information Officer, Nuance

      • Julie Agez, IT Project Manager Antoine Lacassagne Centre for the Fight against Cancer, Unicancer Network

      • Moderator; Elena Bonfiglioli, GM, Worldwide Healthcare, Strategy Lead, Pharma and Life Sciences, Microsoft

  • 12:45 - 13:40
    LUNCH & NETWORKING
  • TRACK 1: PRACTICAL, REAL-WORLD AI USE CASES IN HEALTHCARE. Examining the potential to transform care delivery and life science research, challenges faced and lessons learnt. ROOM: EVENT HALL Chair: Babita Sharma, Broadcaster and Author
    • 13:40 - 14:00
      HEADLINER Use Case 5 Examining how the European Space Agency develops technologies that find applications in life sciences Arnaud Runge, Medical Engineer, European Space Agency

      Health is not yet a topic immediately associated with space exploration. However, hundreds, thousands of kilometres (and beyond) from Earth, there are no hospitals, possibly no doctors, and yet astronauts still need access to care, should it be for prevention, monitoring and diagnosis or treatment purposes. For this reason, the European Space Agency (ESA) is investing in innovative healthcare technologies. Advantageously, all the limitations in space spark innovations in telemedicine, robotics, and AI that will also very often help patients on Earth.

      • Arnaud Runge, Medical Engineer, European Space Agency

    • 14:00 - 14:20
      Use Case 6: End-to-End AI-driven Robotic Drug Discovery and Case Study of the First AI-Discovered and AI-Designed Therapeutic in Human Clinical Trials Alex Zhavoronkov, Founder and CEO, Insilico Medicine

      Since 2014, AI systems have advanced and outperformed humans in many areas. However, in drug discovery and development the number of drugs where the target was discovered using AI or a small molecule was designed using AI is surprisingly small. Here we will present the case study of the first AI-discovered target and AI-designed molecule targeting fundamental pathways implicated in ageing and chronic diseases reaching human clinical trials. We will also present how this process of target discovery and validation can be accelerated and improved using AI-driven robotics systems.

      • Alex Zhavoronkov, Founder and CEO, Insilico Medicine

    • 14:20 - 14:40
      Use Case 7: Enhancing Clinical Care by Developing and Applying AI Within a Health System Dr Sumeet S. Chugh, Director, Division of Artificial Intelligence in Medicine; Director, Center for Cardiac Arrest Prevention, Smidt Heart Institute; Cedars-Sinai Health System

      There are significant advantages to developing and testing health care AI within learning health systems. The Division of Artificial Intelligence in Medicine in the Cedars-Sinai Health System, Los Angeles, enables cross-disciplinary connections between clinicians, scientists, and trainees within the health system. We employ a patient and disease-based approach for the development of novel clinical tools that address major knowledge gaps in health care.

      • Dr Sumeet S. Chugh, Director, Division of Artificial Intelligence in Medicine; Director, Center for Cardiac Arrest Prevention, Smidt Heart Institute; Cedars-Sinai Health System

    • 14:40 - 15:00
      Use Case 8: CURIAL - Rapid Screening for COVID-19 in Emergency Departments Dr Andrew Soltan, NIHR Academic Clinical Fellow, University of Oxford & Oxford University Hospitals NHS Foundation Trust

      Delays in COVID-19 testing can contribute to operational pressures & treatment delays in hospital emergency departments. We discuss how a cross-disciplinary team at Oxford University developed an AI-driven screening test for COVID-19 in Emergency Departments, using clinical data routinely collected within an hour of a patient arriving. During a pilot at Oxford’s John Radcliffe Hospital, CURIAL results were available just 45 minutes after a patient first registered in the emergency department; 16 minutes sooner than Lateral Flow test results and 6:52h sooner than PCR results. Moreover, the AI was found to have been able to reduce missed COVID-19 cases in emergency admissions by 72% when compared to Lateral Flow Tests alone. 

      • Dr Andrew Soltan, NIHR Academic Clinical Fellow, University of Oxford & Oxford University Hospitals NHS Foundation Trust

    • 15:00 - 15:20
      Use Case 9 How AI can shape better clinical trials Eric Durand, SVP Data Science, Owkin

      Clinical trials success rates remain low, especially in oncology. To address this, Owkin has developed innovative Machine Learning approaches which can significantly de-risk and accelerate clinical trials. Here, Eric will present two ML approaches to optimise clinical development. The first applies to early phase trials, where ML methods leveraging external control arms can greatly de-risk further trials. The second applies to Randomised Controlled Trials and can significantly increase the statistical power of the trial.

      • Eric Durand, SVP Data Science, Owkin

    • 15:20 - 15:40
      Use Case 10 AI-based Patient Needs Management Michal Dubno, Head of Outpatient Scheduling, LUX MED

      LUX MED is the largest private provider of outpatient services in Poland.  >200 outpatient clinics, 14 hospitals, 8000 doctors. At the same time, we are the insurer so we believe that smooth and effective treatment is the key for the satisfaction of patients and for our profitability. Symptom checkers are useful in the process of outpatient scheduling but usually they are based only on the answers from patients and are external boxes not connected with EHR systems. Our system is larger than the symptom checker. We call it Patient Need Management system. The system doesn’t need to ask all the questions because it can check data in patients’ records. In this talk, Michal will share how they built it and the efficiencies it made.

      • Michal Dubno, Head of Outpatient Scheduling, LUX MED

  • TRACK 2: DEEP DIVE AI TECH TALKS IN HEALTHCARE Fundamental breakthroughs using AI which will change lives and reshape healthcare ROOM: BOSTON Chair: Anca del Río, Lead Health Tech Community & Stakeholder Relations, DayOne - Healthcare Innovation
    • 13:40 - 14:00
      Tech Talk 7 How Deep Learning has revolutionized 3D modelling in drug discovery Giuseppe Marco Randazzo, Head of AI and Cheminformatics, Endogena Therapeutics, Inc

      Three-dimensional (3D) modelling in the drug development pipeline allows a rational explanation of the intermolecular interactions involved in new medicines.

      With new technologies such as deep learning, this process is changing and becoming more efficient. Indeed, convolutional layers offer the possibility to learn and produce machine learning models directly from 3D molecular representation without requiring any hand-designed visual feature. However, these technologies are very time-consuming and costly.

      In this talk, we will try to understand if this technology is worth it by using two case studies as examples: the retention time prediction for the identification of steroids in biological samples and the prediction of the steroid’s binding affinity to carrier proteins.

      • Giuseppe Marco Randazzo, Head of AI and Cheminformatics, Endogena Therapeutics, Inc

    • 14:00 - 14:20
      Tech Talk 8: AI For your Eye Karthik Kannan, Co-founder & CTO, Envision

      AI has many potential applications but the one area where it’s already creating lifechanging, and heard of the least, is Accessibility. Applied Computer Vision and Smart Glasses has been helping people with visual disabilities read millions of documents or books, recognise their loved ones even customise AI models to tell the difference between their favourite coffee mugs or find an empty seat. All of this is happening today, as you read this.

      This talk will look at building Envision Glasses & Envision app, helping over 50,000 visually impaired people across the world live more independently. Karthik will be sharing learnings in building AI for accessibility, deploying them to smart glasses & what advancements on the horizon will enable the next wave of independence.

      • Karthik Kannan, Co-founder & CTO, Envision

    • 14:20 - 14:40
      Tech Talk 9 Hyper-accelerate drug and medical device development using AI & Modeling following FDA's and EMA’s recommendations Luca Emili, CEO &Founder InSilicoTrials

      Drug development costs and timelines continue to increase. An in silico approach is key to hyper-accelerate clinical trials and cut up to 50% of the cost and time of drug and medical device development, while significantly reducing animal and human testing.

      Luca Emili will highlight how Digital Twin and Biosimulation became key to cutting down time frames and costs in the Life Science industry, with two trends pushing heavily in this direction: regulatory bodies (both the Food & Drug Administration and European Medicines Agency endorse these technologies) and the disruptive impact of the pandemic on Pharma and MedTech R&D, paving the way to a new trial paradigm.

      • Luca Emili, CEO &Founder InSilicoTrials

    • 14:40 - 15:00
      Tech Talk 10 How to leverage Computer Vision & NLP to improve the quality of digital health Steven Truong, Founder and CEO, VinBrain

      By deployment to more than 100 hospitals for DrAid™, our 1st AI-aided radiologist’s platform in Vietnam and the USA; and by having sizable users based for AIviCare™, an AI Telehealth and smart Electronic Health Records (EHR) based a mobile-cloud deployment model, VinBrain is looking forward for sharing our business-driven technologies challenges, insights, and how we’re looking forward to creating break-throughs in deep-tech to address multi-modalities and time-series spaces, targeting more comprehensive solutions for the future of digital health.

      • Steven Truong, Founder and CEO, VinBrain

    • 15:00 - 15:20
      Tech Talk 11: The Digital Pill: Using a second-generation AI for improving effectiveness of chronic drugs Yaron Ilan, Director of the Department of Medicine, Hebrew University-Hadassah Medical Center
      Dr Noa Hurvitz, Resident, Department of Medicine, Hebrew University-Hadassah Medical Center

      The Digital Pill combines a personalized second-generation artificial intelligence system with a branded or generic drug and improves medication response. It provides advantages for all players in the healthcare system, including patients, clinicians, healthcare authorities, and insurance companies. The system provides drug manufacturers with a market differentiator for branded and generic drugs

      • Yaron Ilan, Director of the Department of Medicine, Hebrew University-Hadassah Medical Center

      • Dr Noa Hurvitz, Resident, Department of Medicine, Hebrew University-Hadassah Medical Center

    • 15:20 - 15:40
      Tech Talk 12: Automated recognition of function, activity and participation of COVID-19 patients with NLP Edwin Geleijn, Physiotherapist / healthcare innovator, Amsterdam UMC

      Electronic health records consist for over 60% of unstructured data, mainly as notes of healthcare professionals and medical specialists. Within these notes healthcare professionals make subtle statements with regard to the patients functioning.  With natural language processing the A-proof team has created a means to derive structured data out of textual data. Thus creating endless possibilities for data driven healthcare.

      • Edwin Geleijn, Physiotherapist / healthcare innovator, Amsterdam UMC

  • TRACK 3: INNOVATION STAGE: AI HEALTH TRANSFORMERS. Hear from the leaders of the most disruptive AI health tech companies of tomorrow. ROOM: SHANGHAI Chair: Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland
    • 13:40 - 15:00
      Innovation Insight 7 The impact of NLP technology on regulatory activities André Dias, Chief Commercial Officer, Giotto.ai

      Welcome to a future where NLP technology supports humans in the most time-consuming and error-prone regulatory activities. Understand how Medical Device companies are already using regulatory intelligence tools to tackle the recent European Regulation (EUMDR)

      • André Dias, Chief Commercial Officer, Giotto.ai

    • 14:00 - 14:20
      Innovation Insight 8 Pharma in 2032: the role of RWE Dr. Matteo Togninalli, Chief Operational Officer, Visium

      From cost and competitive pressures to regulatory and patients needs shifts, today’s healthcare actors must focus on value and patient outcomes.

      Recent progress in advanced analytics are transforming real-world evidence (RWE) into actionable insights that improve clinical and economic outcomes.

      In this talk, we explore concrete opportunities from advanced RWE analytics and the impact it delivers at scale, estimated at $300 million per year over the next three to five years for an average pharma company.

      • Dr. Matteo Togninalli, Chief Operational Officer, Visium

    • 14:20 - 15:40
      Startups Showcase Startups:
      Anton Balakirev, CTO, Acrux Cyber Services
      Luca Jahreiss, Co-founder & Chief Marketing Officer, Ancora.ai
      Yana Kozis, CEO and Founder, Debaby
      Jennifer Goodall, CEO, MindAffect
      Rishi Das-Gupta, Co-Founder, NodeNS
      Judges:
      Cécile Tardy-Srinivasan, DayOne Health 4.0 Accelerator Manager, DayOne
      Niels Van Espen, Health Innovation & Design Director, Made
      Fabian Scheugenpflug, Investor & Senior Ventures Associate, Plug and Play Health EMEA
      Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland

      Five AI startups short-listed for our showcase get 10 minutes to pitch their business idea to four judges. 

       

      After each pitch, judges get 5 minutes to ask questions about the venture.

      • Startups:

      • Anton Balakirev, CTO, Acrux Cyber Services

      • Luca Jahreiss, Co-founder & Chief Marketing Officer, Ancora.ai

      • Yana Kozis, CEO and Founder, Debaby

      • Jennifer Goodall, CEO, MindAffect

      • Rishi Das-Gupta, Co-Founder, NodeNS

      • Judges:

      • Cécile Tardy-Srinivasan, DayOne Health 4.0 Accelerator Manager, DayOne

      • Niels Van Espen, Health Innovation & Design Director, Made

      • Fabian Scheugenpflug, Investor & Senior Ventures Associate, Plug and Play Health EMEA

      • Frank Dannacher, Director, AI & Data Practice Lead for Life Science and Healthcare, Deloitte Switzerland

  • TRACK 4: AI UNDER THE HOOD: WORKSHOPS. ROOM: DELHI
    • 13:40 - 14:40
      Workshop 4 The Power of Opportunistic Detection using AI Dr. Jacob J Visser, Radiologist & CMIO, Assistant professor Value-Based Imaging, Erasmus Medical Center
      Thomas Lindahl, Chief Medical Officer, Unilabs Sweden
      Michael Zaiac, ORE Medical Affairs Head, Novartis
      Moderator: Rohit Ghosh, Chief Strategy Officer, Founding Member, Qure.ai

      Billions of scans are acquired each year for various medical reasons and as part of routine check-ups. Imagine the potential if every radiology exam ordered could be surveilled using AI in under minutes and scans indicative of risk for different disease can be flagged for further action. Apart from giving the healthcare practices an added layer of confidence, it provides the patient with a two step-check for early intervention- in other words, a safety net.   

      This panel discussion aims to draw attention to the potential of AI interventions in enabling timely diagnosis.

      • Dr. Jacob J Visser, Radiologist & CMIO, Assistant professor Value-Based Imaging, Erasmus Medical Center

      • Thomas Lindahl, Chief Medical Officer, Unilabs Sweden

      • Michael Zaiac, ORE Medical Affairs Head, Novartis

      • Moderator: Rohit Ghosh, Chief Strategy Officer, Founding Member, Qure.ai

    • 14:40 - 15:40
      Workshop 5: Can we holistically quantify financial returns for investment made in hospital AI? Workshop Hosts: Prateek Bharadwaj, Global Market Access Manager, Radiology, Bayer AG
      Michael Blankenburg, Market Access Manager, Radiology, Bayer AG
      Juan Gutiérrez Alliende, Medical Lead EMEA Digital Solution Business, Radiology, Bayer AG

      AI-supported digital applications are being developed by Bayer which aim to support the radiologists manage their daily workload by the virtue of augmented efficiency, enriched information, and potentially improved patient outcomes. This interactive workshop explores how we can translate these value attributes into a tangible and measurable benefits (KPIs) framework.

      • Workshop Hosts: Prateek Bharadwaj, Global Market Access Manager, Radiology, Bayer AG

      • Michael Blankenburg, Market Access Manager, Radiology, Bayer AG

      • Juan Gutiérrez Alliende, Medical Lead EMEA Digital Solution Business, Radiology, Bayer AG

    • 15:45 - 16:45
      Workshop 6 Value-based healthcare (VBHC): How can technology be used in the automation of VBHC and what could be the role of AI in its optimisation and to achieve scale? Mark Chalmers, Life Sciences Consulting, Partner, EY
      Maurice Perrinjaquet, Life Sciences Consulting, Partner, EY
      Sean O’Pray, Health Outcomes Platform Director, EY
      Binara Rupasinghe, Life Sciences Consulting, Director, EY

      Public health systems all over the world are under great pressure to deliver value for money at a time when demand for care is growing and innovative, high cost medicines are coming to market. Value-based healthcare include innovative types of payment model that tie the price of a drug and supporting patient services to specific health, economic or experience outcomes and represents an innovative solution to overcome these healthcare system challenges.

      However, challenges to scaling value-based healthcare persist. Join our session to hear how the EY Health Outcomes Platform has been designed to overcome operational challenges and explore how AI can be utilised to optimise and scale value-based healthcare for all.

      • Mark Chalmers, Life Sciences Consulting, Partner, EY

      • Maurice Perrinjaquet, Life Sciences Consulting, Partner, EY

      • Sean O’Pray, Health Outcomes Platform Director, EY

      • Binara Rupasinghe, Life Sciences Consulting, Director, EY

  • 15:40 - 16:00
    REFRESHMENTS & NETWORKING
  • 16:00 - 16:25
    IN CONVERSATION Reimagining the Future of Health: Leveraging technological innovation to mitigate disparities in healthcare and ensure equitable access to medicine for all Dr Carl Leitner, Technical Officer - Digital Health & Innovation, World Health Organisation
    Dr Ursula Jasper, Governance and Policy Lead, Fondation Botnar
    Interviewer: Stefan Germann, CEO, Fondation Botnar
    • Dr Carl Leitner, Technical Officer - Digital Health & Innovation, World Health Organisation

    • Dr Ursula Jasper, Governance and Policy Lead, Fondation Botnar

    • Interviewer: Stefan Germann, CEO, Fondation Botnar

  • 16:25 - 16:55
    PANEL DISCUSSION: Avoiding the hype: What will the future of healthcare REALLY look like? Kelly McCain, Head of Health and Healthcare Initiatives, World Economic Forum
    Meni Styliadou, VP Distinguished Fellow, Data Science Institute at Takeda R&D; Founder & Co-Lead of H2O Enterprise
    Dr Loubna Bouarfa, CEO & Founder, OKRA.ai
    Achim Plueckebaum, Head data42, Novartis
    Juan Gutiérrez Alliende, Medical Lead EMEA Digital Solution Business, Radiology, Bayer AG
    Moderator: Vicky Levy, Deloitte Global Life Sciences Sector Leader, Deloitte
    • Kelly McCain, Head of Health and Healthcare Initiatives, World Economic Forum

    • Meni Styliadou, VP Distinguished Fellow, Data Science Institute at Takeda R&D; Founder & Co-Lead of H2O Enterprise

    • Dr Loubna Bouarfa, CEO & Founder, OKRA.ai

    • Achim Plueckebaum, Head data42, Novartis

    • Juan Gutiérrez Alliende, Medical Lead EMEA Digital Solution Business, Radiology, Bayer AG

    • Moderator: Vicky Levy, Deloitte Global Life Sciences Sector Leader, Deloitte

  • 17:00 - 17:00
    CLOSE OF INTELLIGENT HEALTH

Don’t miss out!

Sign up now and get the latest news and ticket deals!

SUBSCRIBE NOW